Literature DB >> 28090301

Pulmonary pulse wave transit time is associated with right ventricular-pulmonary artery coupling in pulmonary arterial hypertension.

Kurt W Prins1, E Kenneth Weir1, Stephen L Archer2, Jeremy Markowitz1, Lauren Rose1, Marc Pritzker1, Richard Madlon-Kay1, Thenappan Thenappan1.   

Abstract

Pulmonary pulse wave transit time (pPTT), defined as the time for the systolic pressure pulse wave to travel from the pulmonary valve to the pulmonary veins, has been reported to be reduced in pulmonary arterial hypertension (PAH); however, the underlying mechanism of reduced pPTT is unknown. Here, we investigate the hypothesis that abbreviated pPTT in PAH results from impaired right ventricular-pulmonary artery (RV-PA) coupling. We quantified pPTT using pulsed-wave Doppler ultrasound from 10 healthy age- and sex-matched controls and 36 patients with PAH. pPTT was reduced in patients with PAH compared with controls. Univariate analysis revealed the following significant predictors of reduced pPTT: age, right ventricular fractional area change (RV FAC), tricuspid annular plane excursion (TAPSE), pulmonary arterial pressures (PAP), diastolic pulmonary gradient, transpulmonary gradient, pulmonary vascular resistance, and RV-PA coupling (defined as RV FAC/mean PAP or TAPSE/mean PAP). Although the correlations between pPTT and invasive markers of pulmonary vascular disease were modest, RV FAC (r = 0.64, P < 0.0001), TAPSE (r = 0.67, P < 0.0001), and RV-PA coupling (RV FAC/mean PAP: r = 0.72, P < 0.0001; TAPSE/mean PAP: r = 0.74, P < 0.0001) had the strongest relationships with pPTT. On multivariable analysis, only RV FAC, TAPSE, and RV-PA coupling were independent predictors of pPTT. We conclude that shortening of pPTT in patients with PAH results from altered RV-PA coupling, probably occurring as a result of reduced pulmonary arterial compliance. Thus, pPTT allows noninvasive determination of the status of both the pulmonary vasculature and the response of the RV in patients with PAH, thereby allowing monitoring of disease progression and regression.

Entities:  

Keywords:  echocardiography; pulse wave velocity; right ventricular–pulmonary artery coupling

Year:  2016        PMID: 28090301      PMCID: PMC5210075          DOI: 10.1086/688879

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  42 in total

1.  Right ventricular function in heart failure with preserved ejection fraction: a community-based study.

Authors:  Selma F Mohammed; Imad Hussain; Omar F AbouEzzeddine; Omar F Abou Ezzeddine; Hiroyuki Takahama; Susan H Kwon; Paul Forfia; Véronique L Roger; Margaret M Redfield
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

2.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Authors:  Micah R Fisher; Paul R Forfia; Elzbieta Chamera; Traci Housten-Harris; Hunter C Champion; Reda E Girgis; Mary C Corretti; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2009-01-22       Impact factor: 21.405

3.  Non-invasive indices of right ventricular function are markers of ventricular-arterial coupling rather than ventricular contractility: insights from a porcine model of chronic pressure overload.

Authors:  Julien Guihaire; Francois Haddad; David Boulate; Benoît Decante; Andre Y Denault; Joseph Wu; Philippe Hervé; Marc Humbert; Philippe Dartevelle; Jean-Philippe Verhoye; Olaf Mercier; Elie Fadel
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-05-15       Impact factor: 6.875

4.  Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.

Authors:  Mads J Andersen; Seok-Jae Hwang; Garvan C Kane; Vojtech Melenovsky; Thomas P Olson; Kenneth Fetterly; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2015-04-09       Impact factor: 8.790

5.  Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients.

Authors:  P J Currie; J B Seward; K L Chan; D A Fyfe; D J Hagler; D D Mair; G S Reeder; R A Nishimura; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1985-10       Impact factor: 24.094

6.  Pulmonary capillary wedge pressure augments right ventricular pulsatile loading.

Authors:  Ryan J Tedford; Paul M Hassoun; Stephen C Mathai; Reda E Girgis; Stuart D Russell; David R Thiemann; Oscar H Cingolani; James O Mudd; Barry A Borlaug; Margaret M Redfield; David J Lederer; David A Kass
Journal:  Circulation       Date:  2011-11-30       Impact factor: 29.690

7.  Noninvasive estimation of pulmonary vascular resistance in pulmonary hypertension.

Authors:  Navin Rajagopalan; Marc A Simon; Matthew S Suffoletto; Hemal Shah; Kathy Edelman; Michael A Mathier; Angel López-Candales
Journal:  Echocardiography       Date:  2008-11-24       Impact factor: 1.724

8.  RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension.

Authors:  Rebecca R Vanderpool; Michael R Pinsky; Robert Naeije; Christopher Deible; Vijaya Kosaraju; Cheryl Bunner; Michael A Mathier; Joan Lacomis; Hunter C Champion; Marc A Simon
Journal:  Heart       Date:  2014-09-11       Impact factor: 5.994

9.  Pulmonary artery pulse wave velocity in idiopathic pulmonary arterial hypertension.

Authors:  Grzegorz Kopeć; Deddo Moertl; Piotr Jankowski; Anna Tyrka; Bartosz Sobień; Piotr Podolec
Journal:  Can J Cardiol       Date:  2012-12-20       Impact factor: 5.223

10.  Echocardiographic predictors of mortality in patients with pulmonary hypertension and cardiopulmonary comorbidities.

Authors:  Johannes Steiner; Wen-Chih Wu; Matthew Jankowich; Bradley A Maron; Satish Sharma; Gaurav Choudhary
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

View more
  12 in total

1.  Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.

Authors:  Lauren Rose; Kurt W Prins; Stephen L Archer; Marc Pritzker; E Kenneth Weir; Jeffrey R Misialek; Thenappan Thenappan
Journal:  J Heart Lung Transplant       Date:  2018-09-14       Impact factor: 10.247

2.  Disproportionate Right Ventricular Dysfunction and Poor Survival in Group 3 Pulmonary Hypertension.

Authors:  Kurt W Prins; Lauren Rose; Stephen L Archer; Marc Pritzker; E Kenneth Weir; Felipe Kazmirczak; Jeffrey R Misialek; Thenappan Thenappan
Journal:  Am J Respir Crit Care Med       Date:  2018-06-01       Impact factor: 21.405

3.  Compromised Cardiopulmonary Function in Fibulin-5 Deficient Mice.

Authors:  Abhay B Ramachandra; Nicole Mikush; Maor Sauler; Jay D Humphrey; Edward P Manning
Journal:  J Biomech Eng       Date:  2022-08-01       Impact factor: 1.899

4.  Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility.

Authors:  Sasha Z Prisco; Lynn M Hartweck; Lauren Rose; Patricia D A Lima; Thenappan Thenappan; Stephen L Archer; Kurt W Prins
Journal:  Circ Heart Fail       Date:  2021-12-20       Impact factor: 10.447

5.  Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension.

Authors:  Kurt W Prins; Rajat Kalra; Lauren Rose; Tufik R Assad; Stephen L Archer; Navkaranbir S Bajaj; E Kenneth Weir; Sasha Z Prisco; Marc Pritzker; Pamela L Lutsey; Evan L Brittain; Thenappan Thenappan
Journal:  J Am Heart Assoc       Date:  2020-02-21       Impact factor: 5.501

6.  Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension.

Authors:  Kurt W Prins; Stephen L Archer; Marc Pritzker; Lauren Rose; E Kenneth Weir; Alok Sharma; Thenappan Thenappan
Journal:  J Heart Lung Transplant       Date:  2017-09-01       Impact factor: 10.247

7.  Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension.

Authors:  Khodr Tello; Jun Wan; Antonia Dalmer; Rebecca Vanderpool; Hossein A Ghofrani; Robert Naeije; Fritz Roller; Emad Mohajerani; Werner Seeger; Ulrike Herberg; Natascha Sommer; Henning Gall; Manuel J Richter
Journal:  Circ Cardiovasc Imaging       Date:  2019-09-10       Impact factor: 7.792

8.  Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.

Authors:  Lian Tian; Danchen Wu; Asish Dasgupta; Kuang-Hueih Chen; Jeffrey Mewburn; Francois Potus; Patricia D A Lima; Zhigang Hong; Yuan-Yuan Zhao; Charles C T Hindmarch; Shelby Kutty; Steeve Provencher; Sebastien Bonnet; Gopinath Sutendra; Stephen L Archer
Journal:  Circ Res       Date:  2020-03-27       Impact factor: 17.367

9.  Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.

Authors:  Kurt W Prins; Lian Tian; Danchen Wu; Thenappan Thenappan; Joseph M Metzger; Stephen L Archer
Journal:  J Am Heart Assoc       Date:  2017-05-31       Impact factor: 5.501

10.  Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease.

Authors:  Kurt W Prins; Lauren Rose; Stephen L Archer; Marc Pritzker; E Kenneth Weir; Matthew D Olson; Thenappan Thenappan
Journal:  J Am Heart Assoc       Date:  2019-01-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.